Firms
Theme

ZUMZ

Zumiez Inc. · NASDAQ

News

3 latest

Zacks Investment Research

Zumiez's Private Label and Product Newness Help Sustain Global Gains

Zumiez (ZUMZ) is pursuing international growth through private-label expansion and distinctive merchandise while addressing weakness in its U.S. business. Europe and Australia net sales rose 2.5% to $35.1 million in Q2 fiscal 2026. The company is implementing premium pricing and expense management to improve margins, though shares have declined 20.4% in three months and the stock trades at a premium valuation of 19.25x forward P/E versus the industry average of 12.97x.

Zacks Investment Research

Can Zumiez's Data-Driven Marketing Improve Customer Engagement?

Zumiez (ZUMZ) is using data analytics to improve customer insights and marketing effectiveness while working to enhance customer experience through operational changes. However, the company faces headwinds from U.S. sales deceleration driven by footwear softness and declining transactions. Management views the downturn as temporary and is refining merchandise assortments to navigate this transitional period.

Mentions ZUMZ

Zacks Investment Research

Why Is Stitch Fix (SFIX) Up 23.1% Since Last Earnings Report?

Stitch Fix reported a narrower-than-expected Q4 adjusted loss and revenue growth, with revenue per active client reaching a record $592. However, active client count declined 1.4%, and management expects a more challenging consumer environment and higher acquisition costs in fiscal 2027.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $ZUMZ · 0 threads

Sign in to post on $ZUMZ

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev